Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 May;91(5):1964–1968. doi: 10.1172/JCI116416

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

L X Fu 1, Y Magnusson 1, C H Bergh 1, J A Liljeqvist 1, F Waagstein 1, A Hjalmarson 1, J Hoebeke 1
PMCID: PMC288192  PMID: 7683693

Abstract

A peptide corresponding to the sequence 169-193 of the second extracellular loop of the human muscarinic acetylcholine receptor-2 was used as an antigen to screen sera from patients with idiopathic dilated cardiomyopathy (DCM, n = 36) and healthy blood donors (HBD, n = 40). The sera from 14 patients with DCM (38.8%) and 3 HBD (7.5%) recognized the muscarinic receptor peptide at dilutions varying from 1:20 to 1:160 in ELISA. A highly significant correlation (P = 0.006) was found between the presence of antimuscarinic receptor-2 autoantibodies and anti-beta-adrenoceptor-1 autoantibodies in the patients' sera. Affinity-purified autoantibodies from positive sera of patients with DCM recognized on the electrotransferred protein of rat ventricular membrane a major band of about 80 kD. Incubation of autoantibodies with membrane resulted not only in a decrease in the maximal binding sites (Bmax) but also in an increase in Kd of radioligand binding in a concentration-dependent manner. This suggests a mixed-type of inhibition. Moreover, preincubation with atropine abolished the inhibitory effect of autoantibodies on the receptor binding whereas carbachol appeared to have no effect on the activity of the autoantibodies. These data define a subgroup of patients with idiopathic DCM who have in their sera functionally active autoantibodies against muscarinic receptor-2.

Full text

PDF
1964

Images in this article

1965Image
on p.1965
1966Image
on p.1966

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. André C., Guillet J. G., De Backer J. P., Vanderheyden P., Hoebeke J., Strosberg A. D. Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors. EMBO J. 1984 Jan;3(1):17–21. doi: 10.1002/j.1460-2075.1984.tb01755.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blecher M., Lewis S., Hicks J. M., Josephs S. Beta-blocking autoantibodies in pediatric bronchial asthma. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):246–251. doi: 10.1016/0091-6749(84)90253-7. [DOI] [PubMed] [Google Scholar]
  3. Borda E., Pascual J., Cossio P., De La Vega M., Arana R., Sterin-Borda L. A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin Exp Immunol. 1984 Sep;57(3):679–686. [PMC free article] [PubMed] [Google Scholar]
  4. Caforio A. L., Bonifacio E., Stewart J. T., Neglia D., Parodi O., Bottazzo G. F., McKenna W. J. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990 Jun;15(7):1527–1534. doi: 10.1016/0735-1097(90)92821-i. [DOI] [PubMed] [Google Scholar]
  5. Caforio A. L., Stewart J. T., Bonifacio E., Burke M., Davies M. J., McKenna W. J., Bottazzo G. F. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun. 1990 Apr;3(2):187–200. doi: 10.1016/0896-8411(90)90140-n. [DOI] [PubMed] [Google Scholar]
  6. Das S. K., Cassidy J. T., Petty R. E. Antibodies against heart muscle and nuclear constituents in cardiomyopathy. Am Heart J. 1972 Feb;83(2):159–166. doi: 10.1016/0002-8703(72)90134-2. [DOI] [PubMed] [Google Scholar]
  7. Eng H., Magnusson Y., Matell G., Lefvert A. K., Saponja R., Hoebeke J. Beta 2-adrenergic receptor antibodies in myasthenia gravis. J Autoimmun. 1992 Apr;5(2):213–227. doi: 10.1016/0896-8411(92)90201-z. [DOI] [PubMed] [Google Scholar]
  8. Fowles R. E., Bieber C. P., Stinson E. B. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation. 1979 Mar;59(3):483–491. doi: 10.1161/01.cir.59.3.483. [DOI] [PubMed] [Google Scholar]
  9. Fu L. X., Bergh C. H., Hoebeke J., Liang Q. M., Sjögren K. G., Waagstein F., Hjalmarson A. Effect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicity. Basic Res Cardiol. 1991 Mar-Apr;86(2):117–126. doi: 10.1007/BF02190544. [DOI] [PubMed] [Google Scholar]
  10. Goodwin J. F. Mechanisms in cardiomyopathies. J Mol Cell Cardiol. 1985 Jul;17 (Suppl 2):5–9. doi: 10.1016/0022-2828(85)90003-3. [DOI] [PubMed] [Google Scholar]
  11. Haga T., Haga K., Berstein G., Nishiyama T., Uchiyama H., Ichiyama A. Molecular properties of muscarinic receptors. Trends Pharmacol Sci. 1988 Feb;Suppl:12–18. [PubMed] [Google Scholar]
  12. Limas C. J., Goldenberg I. F., Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res. 1989 Jan;64(1):97–103. doi: 10.1161/01.res.64.1.97. [DOI] [PubMed] [Google Scholar]
  13. Magnusson Y., Marullo S., Hoyer S., Waagstein F., Andersson B., Vahlne A., Guillet J. G., Strosberg A. D., Hjalmarson A., Hoebeke J. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1990 Nov;86(5):1658–1663. doi: 10.1172/JCI114888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Magnusson Y., Wallukat G., Guillet J. G., Hjalmarson A., Hoebeke J. Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmun. 1991 Dec;4(6):893–905. doi: 10.1016/0896-8411(91)90052-e. [DOI] [PubMed] [Google Scholar]
  15. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. doi: 10.1016/0092-8674(87)90507-1. [DOI] [PubMed] [Google Scholar]
  16. Paaerez Leirós C., Sterin-Borda L., Cossio P., Borda E. S. Muscarinic cholinergic antibody in experimental autoimmune myocarditis regulates cardiac function. Proc Soc Exp Biol Med. 1990 Dec;195(3):356–363. doi: 10.3181/00379727-195-43155. [DOI] [PubMed] [Google Scholar]
  17. Peralta E. G., Winslow J. W., Peterson G. L., Smith D. H., Ashkenazi A., Ramachandran J., Schimerlik M. I., Capon D. J. Primary structure and biochemical properties of an M2 muscarinic receptor. Science. 1987 May 1;236(4801):600–605. doi: 10.1126/science.3107123. [DOI] [PubMed] [Google Scholar]
  18. Savarese T. M., Wang C. D., Fraser C. M. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. J Biol Chem. 1992 Jun 5;267(16):11439–11448. [PubMed] [Google Scholar]
  19. Schultheiss H. P., Schwimmbeck P., Bolte H. D., Klingenberg M. The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol. 1985;6:311–327. [PubMed] [Google Scholar]
  20. Tzartos S. J., Kokla A., Walgrave S. L., Conti-Tronconi B. M. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit. Proc Natl Acad Sci U S A. 1988 May;85(9):2899–2903. doi: 10.1073/pnas.85.9.2899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Venter J. C., Fraser C. M., Chung F. Z., Kerlavage A. R., Robinson D. A., Gocayne J. D., FitzGerald M. G. Cloning and expression of adrenergic and muscarinic cholinergic receptor genes. Adv Exp Med Biol. 1988;236:173–180. doi: 10.1007/978-1-4757-5971-6_14. [DOI] [PubMed] [Google Scholar]
  22. Venter J. C., Fraser C. M., Harrison L. C. Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma. Science. 1980 Mar 21;207(4437):1361–1363. doi: 10.1126/science.6153472. [DOI] [PubMed] [Google Scholar]
  23. Wolfgram L. J., Beisel K. W., Rose N. R. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med. 1985 May 1;161(5):1112–1121. doi: 10.1084/jem.161.5.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES